Literature DB >> 17582628

Health-related quality of life among patients cured by surgery for esophageal cancer.

Pernilla Lagergren1, Kerry N L Avery, Rachael Hughes, C Paul Barham, Derek Alderson, Stephen J Falk, Jane M Blazeby.   

Abstract

BACKGROUND: Little is known regarding the long-term, health-related quality of life (HRQL) of survivors of esophagectomy for cancer.
METHODS: Consecutive patients completed the validated European Organization for Research and Treatment of Cancer general quality-of life-questionnaire (QLQ-C30) and the esophageal-specific module (QLQ-OES18) before surgery and regularly thereafter for at least 3 years. Mean scores with 95% confidence intervals were calculated. The Student t test for paired data was used to determine differences between baseline and 3-year HRQL scores in which scores differed by >or=5 points.
RESULTS: Of 90 patients who underwent surgery, 47 patients (52%) survived for >or=3 years. In this group, most aspects of HRQL recovered to preoperative levels by the 3-year assessment, except that scores for physical function, breathlessness, diarrhea, and reflux were significantly worse than at baseline (P < .01). However, patients reported significantly better emotional function 3 years after surgery than before treatment (P = .0008).
CONCLUSIONS: Even after 3 years, patients who underwent esophagectomy suffered persistent problems with physical function and specific symptoms. These findings may be used to inform patients of the long-term consequences of surgery. (c) 2007 American Cancer Society.

Entities:  

Mesh:

Year:  2007        PMID: 17582628     DOI: 10.1002/cncr.22833

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  52 in total

1.  Health-related quality of life after Ivor Lewis esophagectomy.

Authors:  Christian A Gutschow; Arnulf H Hölscher; Jessica Leers; Hans Fuchs; Marc Bludau; Klaus L Prenzel; E Bollschweiler; Wolfgang Schröder
Journal:  Langenbecks Arch Surg       Date:  2012-06-04       Impact factor: 3.445

2.  The management of a patient with an operable carcinoma of the oesophagus.

Authors:  Tom Crosby; Mererid Evans; Richard S Gillies; Nicholas D Maynard
Journal:  Ann R Coll Surg Engl       Date:  2009-07       Impact factor: 1.891

Review 3.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

4.  Immunomodulatory function of the active ingredients in traditional Chinese prescriptions on early stage esophageal cancer with dysplasia.

Authors:  Wenbo Jiang; Ning Qin; Tao Chen; Junwei Xu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

5.  Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy.

Authors:  Yajuan Lv; Jiandong Zhang; Lili Qiao
Journal:  Mol Clin Oncol       Date:  2014-06-12

6.  Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?

Authors:  Hans Fuchs; Arnulf H Hölscher; Jessica Leers; Marc Bludau; Sebastian Brinkmann; Wolfgang Schröder; Hakan Alakus; Stefan Mönig; Christian A Gutschow
Journal:  Gastric Cancer       Date:  2015-01-28       Impact factor: 7.370

7.  Effects of Chinese medicine five-element music on the quality of life for advanced cancer patients: a randomized controlled trial.

Authors:  Juan Liao; Yu-fei Yang; Lorenzo Cohen; Yuan-chen Zhao; Yun Xu
Journal:  Chin J Integr Med       Date:  2013-10-04       Impact factor: 1.978

8.  An alternative postoperative pathway reduces length of hospitalisation following oesophagectomy.

Authors:  Sandra C Tomaszek; Stephen D Cassivi; Mark S Allen; K Robert Shen; Francis C Nichols; Claude Deschamps; Dennis A Wigle
Journal:  Eur J Cardiothorac Surg       Date:  2009-11-08       Impact factor: 4.191

9.  Quality of life after three kinds of esophagectomy for cancer.

Authors:  Jian Zeng; Jin-Shi Liu
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

10.  Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.

Authors:  Satoshi Osawa; Takahisa Furuta; Ken Sugimoto; Takashi Kosugi; Tomohiro Terai; Mihoko Yamade; Yasuhiro Takayanagi; Masafumi Nishino; Yasushi Hamaya; Chise Kodaira; Takanori Yamada; Moriya Iwaizumi; Kosuke Takagaki; Ken-ichi Yoshida; Shigeru Kanaoka; Mutsuhiro Ikuma
Journal:  BMC Cancer       Date:  2009-11-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.